Can Wegovy (Semaglutide) Cause Constipation?

How Semaglutide Affects the Digestive System

Semaglutide belongs to a class of medications called GLP-1 receptor agonists. It works by mimicking a hormone your gut naturally releases after eating, which signals your brain that you are full and tells your stomach to slow down emptying its contents. This slowed gastric emptying is central to how the medication reduces appetite and supports weight loss, but it has a direct downstream consequence: food and waste move through your intestines more slowly than usual.

This slowdown in gut motility is not a coincidence or a rare reaction. It is a predictable, pharmacological effect of the drug. The same process that keeps you feeling satisfied after a small meal is the process that can leave you straining in the bathroom days later. Constipation may emerge or worsen during dose escalation, although individual responses vary and clinical-trial data do not establish that risk rises predictably with every dose increase.

How Common Is Constipation on Wegovy

Constipation is not a minor footnote in the semaglutide side effect profile. Clinical trials for Wegovy reported constipation in roughly 24% of participants, placing it among the most common gastrointestinal complaints after nausea. That means approximately one in four people who take Wegovy at the full weight-loss dose may experience it.

The reported frequency is notably higher with Wegovy than with lower-dose semaglutide formulations used primarily for diabetes management, although differences between formulations do not establish that risk rises predictably with every dose increase. Constipation also tends to be most disruptive during dose escalation periods and can improve somewhat as the body adjusts over several weeks, though a new dose increase can reset or worsen symptoms.

The table below summarizes the most common GI side effects reported in Wegovy clinical trials to help put constipation in context.

Who May Be More Vulnerable

While constipation can affect anyone on semaglutide, certain factors may make it more pronounced. Lower baseline fiber and fluid intake amplifies the effect of slowed motility because there is less bulk and water in the stool to keep things moving. People who already have a diet low in fruits, vegetables, and whole grains may notice stronger symptoms.

Reduced appetite is another compounding factor. Because semaglutide significantly decreases how much many people eat, there is simply less food volume passing through the colon. Less input generally means less output and slower transit.

People with a prior history of constipation-predominant irritable bowel syndrome (IBS-C) or slow-transit constipation start from a higher baseline risk. If your digestive system already leans toward sluggishness, semaglutide may intensify that tendency. Taking other medications that slow digestion, such as certain iron supplements or some antidepressants, can stack the effect further and may be worth discussing with your prescriber.

Recognizing Semaglutide-Related Constipation Versus a Red Flag

Typical semaglutide-related constipation presents as fewer than three bowel movements per week, stools that feel hard or lumpy, and straining during bowel movements without an accompanying sense of urgency or rectal bleeding. The timeline is an important clue: if constipation appeared or worsened within days of a dose increase, semaglutide is the most likely explanation.

Some symptoms, however, signal that something beyond medication side effects may be happening and require prompt clinical evaluation. Seek urgent medical care for severe or worsening abdominal pain, marked abdominal swelling, persistent vomiting, inability to pass stool or gas, or signs of dehydration. Rectal bleeding also warrants prompt assessment; heavy bleeding, fainting, or weakness requires emergency care.

Doctronic, which has conducted more than 22 million AI consultations, offers 24/7 access to evaluate symptoms like these so you do not have to wait days for an available appointment to find out whether something warrants attention.

Practical Steps to Find Relief

Most mild to moderate semaglutide-related constipation responds well to straightforward lifestyle adjustments before any medication is needed.

Hydration is the first and most accessible intervention. Aiming for at least eight cups of water daily helps keep stool soft enough to pass without straining. People who are already eating less on semaglutide may also be drinking less, making deliberate hydration even more important.

If you can pass stool and gas and do not have severe pain, vomiting, or marked bloating, a gradual fiber increase with adequate fluid may help. Ask a clinician first if you have suspected obstruction, severe gastroparesis, swallowing difficulty, or a prescribed fluid restriction. Soluble fiber from sources like psyllium husk, oats, and legumes absorbs water and forms a gel that softens stool and encourages movement without the gas and bloating that insoluble fiber can sometimes cause in GLP-1 users. The key word is gradual: adding too much fiber too quickly can worsen discomfort.

Physical activity, even light movement like a 20-minute daily walk, stimulates colonic motility and is fully compatible with weight loss goals. It is one of the few interventions that supports both digestive health and your reason for taking the medication in the first place.

If lifestyle measures are not enough, osmotic laxatives such as polyethylene glycol are generally considered a reasonable short-term option. They work by drawing water into the stool rather than triggering gut contractions, which makes them gentler for most people. Stimulant laxatives are better reserved for occasional use and ideally discussed with a clinician before starting them regularly.

If constipation persists beyond two to three weeks despite these efforts, or if it is severe enough to interfere with daily life, a conversation with your prescribing clinician is the appropriate next step. They may recommend pausing dose escalation, adjusting your regimen, or evaluating whether a different treatment approach suits your situation better.

Frequently Asked Questions

How long does constipation last when starting Wegovy?

Constipation often peaks during the first few weeks at a new dose and may ease as your body adjusts over several weeks. However, each dose escalation step on the standard titration schedule can bring symptoms back. If constipation persists beyond two to three weeks despite lifestyle changes, a clinician review is recommended rather than waiting it out.

Is constipation or diarrhea more common with semaglutide?

Both are possible, but they tend to affect different people. Nausea and constipation are among the most frequently reported GI side effects in clinical trials for Wegovy, with constipation reported in roughly 24% of participants. Diarrhea occurs less often. Because semaglutide slows gut motility, constipation is the more mechanistically expected outcome at higher doses.

What laxative is safe to take with Wegovy?

Osmotic laxatives such as polyethylene glycol (MiraLax) are generally considered a reasonable short-term option and work by drawing water into the stool rather than stimulating gut contractions. Stimulant laxatives should be used sparingly and only after checking with a clinician. Always confirm any new medication or supplement is appropriate for your specific health situation.

Can increasing my semaglutide dose make constipation worse?

Yes. Constipation risk is dose-dependent with semaglutide, meaning each step up in the titration schedule can slow gut motility further. Many people who had adjusted to a lower dose find that constipation returns or worsens after a dose increase. Staying well hydrated and keeping fiber intake consistent during dose changes may help reduce the impact.

Should I stop taking Wegovy if I have severe constipation?

Do not stop Wegovy on your own without speaking to a clinician first. Severe or persistent constipation is a valid reason to contact your prescriber, who may recommend pausing dose escalation, temporarily adjusting your regimen, or evaluating whether a different approach is appropriate. Stopping abruptly can affect your treatment progress and should be a guided decision.

The Bottom Line

Constipation is a well-established, mechanistically understood side effect of semaglutide that affects roughly one in four Wegovy users. Because the medication intentionally slows how quickly food moves through your gut, some degree of digestive slowdown is expected, particularly at higher doses. Catching it early and managing it proactively with hydration, soluble fiber, and gentle movement can make a meaningful difference in your ability to stay on the medication long-term. Doctronic, the first AI legally authorized to practice medicine, offers 24/7 AI consultations with 99.2% treatment plan alignment with board-certified physicians, so you can get personalized guidance quickly without waiting for a scheduled appointment. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.